Protein alterations in ESCC and clinical implications: a review.
about
Genomic and molecular characterization of esophageal squamous cell carcinomaCombined proteasome and histone deacetylase inhibition attenuates epithelial-mesenchymal transition through E-cadherin in esophageal cancer cellsEMP1, a member of a new family of antiproliferative genes in breast carcinoma.Slug down-regulation by RNA interference inhibits invasion growth in human esophageal squamous cell carcinomaTargeted knockdown of IQGAP1 inhibits the progression of esophageal squamous cell carcinoma in vitro and in vivo.Immunohistochemical Analysis of P53 and PRB in Esophageal Squamous Cell CarcinomaGenome-wide screening for genetic alterations in esophageal cancer by aCGH identifies 11q13 amplification oncogenes associated with nodal metastasisIs there a role of whole-body bone scan in patients with esophageal squamous cell carcinoma.A panel of overexpressed proteins for prognosis in esophageal squamous cell carcinoma.Dual high expression of STAT3 and cyclinD1 is associated with poor prognosis after curative resection of esophageal squamous cell carcinoma.ZNF282 (Zinc finger protein 282), a novel E2F1 co-activator, promotes esophageal squamous cell carcinomaOverexpression of OLC1 promotes tumorigenesis of human esophageal squamous cell carcinomaOverexpression of WRAP53 is associated with development and progression of esophageal squamous cell carcinomaSurgical treatments for esophageal cancers.c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic targetInitiation of esophageal squamous cell carcinoma (ESCC) in a murine 4-nitroquinoline-1-oxide and alcohol carcinogenesis model.Expression of Cyclin D1 and P16 in Esophageal Squamous Cell CarcinomaCombined influence of adjuvant therapy and interval after surgery on peripheral CD4(+) T lymphocytes in patients with esophageal squamous cell carcinomaExpression and phosphorylation of stathmin correlate with cell migration in esophageal squamous cell carcinoma.Elevated maspin expression is associated with better overall survival in esophageal squamous cell carcinoma (ESCC).Methylation of TFPI-2 is an early event of esophageal carcinogenesisLong non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinomaPredicting malignant transformation of esophageal squamous cell lesions by combined biomarkers in an endoscopic screening program.Cytokines association with clinical and pathological changes in esophageal squamous cell carcinoma.Molecular alterations and clinical relevance in esophageal squamous cell carcinoma.Epigenetics in esophageal cancers.Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis.Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma.High Expression of GRP78 Promotes Invasion and Metastases in Patients with Esophageal Squamous Cell Carcinoma.Aurora-A enhances malignant development of esophageal squamous cell carcinoma (ESCC) by phosphorylating β-catenin.TPX2 expression is associated with cell proliferation and patient outcome in esophageal squamous cell carcinoma.Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma.A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway.Comprehensive analysis of differential co-expression patterns reveal transcriptional dysregulation mechanism and identify novel prognostic lncRNAs in esophageal squamous cell carcinoma.Overexpression of stathmin plays a pivotal role in the metastasis of esophageal squamous cell carcinoma.Yield of p53 expression in esophageal squamous cell cancer and its relationship with survival.S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells.KLF4 is downregulated but not mutated during human esophageal squamous cell carcinogenesis and has tumor stage-specific functions.Vasculogenic mimicry and aberrant expression of HIF-lα/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma.A nomogram based on phosphorylated AKT1 for predicting locoregional recurrence in patients with oesophageal squamous cell carcinoma.
P2860
Q28657686-F9E9C9E5-94D5-416F-97FB-116D6E41CC88Q30409676-B0EAD029-BC3C-4E14-8309-01E87C8E9CC2Q30729151-DDD38F73-89B2-41EF-BFD0-10462114C28BQ31013515-A08BDC17-0957-4D52-BE1B-16E7802D0C9CQ33572999-5187DC72-8617-4788-8B68-3F8DA332717CQ33839579-A7ECFDE0-4C20-4050-996E-CFC73D52F0BFQ34326537-BB3E2D0F-E34E-47A6-A46E-350B0EDB2418Q34361948-53B951F2-70F8-48CB-874A-4E80BF489544Q34388422-3BC2F93D-6FED-41B3-8F2E-533318D7CDA1Q34733012-8B41B277-0139-4D92-BE55-E0FB8AB7AF78Q35068080-2F6C7E07-E793-4D72-A46E-0A99D780EC95Q35114578-975CDE5C-74BF-4426-9710-F0EC93179489Q35120227-3B6EEF91-1998-40F4-ACE6-9B3D40C77D77Q35256054-9D37B24C-5F8D-4046-ACCF-3D0491315AC2Q35650167-D3EF4C3D-2876-4135-98BA-AC01F027E9E0Q35742458-37EE23FF-98AF-439E-8C59-866E7FBCD2FAQ36306891-C64F6E13-0B64-4DAD-9307-1D68A0B6D765Q36375387-4EAA6DBD-A882-41A4-BCF3-4A5B85DCD449Q36642789-15757649-8556-4FAB-81D5-39EA9A350249Q36867359-D91A009A-959E-4D94-8696-C04F9E10FD58Q37091635-36D997BB-8935-4F17-B2C5-BC5AC3B4BCE8Q37235519-242531A7-9B8D-4C96-B481-3A51D7041F98Q37359615-ADF18BA4-977F-456D-9A6A-C840AE405565Q37424186-6F3398C6-71CC-46D7-8996-BAB21A5B98BCQ38134029-2A10241A-9E09-44DB-A34D-C5AD812DE92DQ38210930-1AC7F02A-8854-4924-828F-2A18E720FAA7Q38422325-BDE3A43B-6617-4DFB-89FA-652CE547A0FDQ38832039-BF34EEE2-1355-48D0-916D-228AA375F4CDQ38874640-0BB105B9-C8C8-4A14-982E-6AF36797B1DFQ38957015-5F2B493E-0A31-4560-9FF2-C0B56504C9A0Q39107387-D8F59D6F-3B53-4919-A6FE-4DBDA66FDBCDQ39677822-346D760C-8B7A-4661-80B8-DB39A13B4489Q39836853-43BA13AF-AFCC-4912-9B64-BF066598B615Q41016101-B1B7DA41-E047-40F1-A3A1-5684C4F9CFC5Q41867931-6E66B5A3-1B65-4083-9D94-7270D96318D2Q41892231-8FCCBF8C-92DB-4F00-B66A-3A44A5CBD995Q42092162-47E081CC-5C8F-4458-BF79-5E4B84079F47Q42688550-7B2074E0-3693-4BCD-8B23-10CA50BC156FQ45938628-0DF99484-7738-43E0-8959-BD1E3AFFC14CQ47118999-0F8FD908-F44A-413B-A813-2FF6CDAC1ABA
P2860
Protein alterations in ESCC and clinical implications: a review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protein alterations in ESCC and clinical implications: a review.
@en
Protein alterations in ESCC and clinical implications: a review.
@nl
type
label
Protein alterations in ESCC and clinical implications: a review.
@en
Protein alterations in ESCC and clinical implications: a review.
@nl
prefLabel
Protein alterations in ESCC and clinical implications: a review.
@en
Protein alterations in ESCC and clinical implications: a review.
@nl
P2093
P2860
P1476
Protein alterations in ESCC and clinical implications: a review.
@en
P2093
P2860
P356
10.1111/J.1442-2050.2008.00845.X
P577
2008-06-17T00:00:00Z